Equity Profile

DGX

Quest Diagnostics Incorporated

Health CareHealth Care Services$23.0B

Jul21Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

Quest Diagnostics Incorporated (DGX) is a leading provider of diagnostic testing services in the healthcare sector. The company plays a crucial role in helping patients and healthcare providers make informed decisions through its extensive range of laboratory tests and services.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors will closely monitor this quarter.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its services and capture market share in the healthcare sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DGX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.79%

Avg Stock Reaction

+3.85%

Last Quarter Recap

In Q1 2026, Quest Diagnostics reported an EPS of $2.50, exceeding expectations by 5.44%. The stock reacted positively, gaining 4.45% the following day.

Management Promises & Guidance

Continued focus on expanding testing services.
Commitment to improving operational efficiency.
Plans to enhance customer experience through technology.

Expectations

Wall Street Expectations

Investors are generally optimistic about Quest Diagnostics' upcoming earnings, given its strong track record of beating EPS estimates. However, the lack of specific guidance adds uncertainty.

Bull Case

If the company continues its trend of beating EPS estimates, it could signal strong operational performance and increased demand for diagnostic services.

Bear Case

On the other hand, any signs of revenue stagnation or increased competition could lead to a negative reaction from investors.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter?

Given the company's history of beating EPS estimates, this figure will be crucial for determining market sentiment post-earnings.

How is revenue growth trending compared to previous quarters?

Revenue growth is a key indicator of the company's market position and ability to attract new customers, which will heavily influence investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Quest Diagnostics' ability to leverage new testing technologies to drive revenue growth this quarter.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational performance.

Options pricing suggests a limited expected move, which may not reflect the potential for a significant positive surprise.

Historical patterns show a strong tendency for the stock to react positively to earnings beats.

Key Risk

If revenue growth exceeds expectations, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Quest Diagnostics can maintain its growth trajectory in a competitive healthcare landscape.

Bull Confirmed If

An EPS of $2.60 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $2.40 could signal potential issues with revenue generation and market competition.

Pre-Earnings Positioning

Options Market

Implied Move

±2.31%

Historical Avg

±5.7%

Pricing cheap

The options market is pricing a relatively modest move in the stock, suggesting that traders expect limited volatility around the earnings announcement.

Options are pricing ±2.3% while DGX has averaged ±5.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

24.2%

Calls (31K)P/C Ratio: 0.25Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Quest Diagnostics beats expectations, history suggests the stock could rise by an average of 3.85%, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with history indicating an average drop of 3.03% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new testing technologies being introduced.
2Management's commentary on operational efficiency improvements.
3Insights into customer demand trends for diagnostic services.
4Any changes to guidance for the upcoming quarters.
5Details on competitive pressures in the healthcare market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

ICICI Bank Limited

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors will closely monitor this quarter.

N/A

Revenue Growth

Revenue growth reflects the company's ability to expand its services and capture market share in the healthcare sector.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

DGX Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+2.79%

Avg Stock Reaction

+3.85%

Last Quarter Recap

In Q1 2026, Quest Diagnostics reported an EPS of $2.50, exceeding expectations by 5.44%. The stock reacted positively, gaining 4.45% the following day.

Management Promises & Guidance

Continued focus on expanding testing services.
Commitment to improving operational efficiency.
Plans to enhance customer experience through technology.

Expectations

Wall Street Expectations

Investors are generally optimistic about Quest Diagnostics' upcoming earnings, given its strong track record of beating EPS estimates. However, the lack of specific guidance adds uncertainty.

Bull Case

If the company continues its trend of beating EPS estimates, it could signal strong operational performance and increased demand for diagnostic services.

Bear Case

On the other hand, any signs of revenue stagnation or increased competition could lead to a negative reaction from investors.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the EPS be this quarter?

Given the company's history of beating EPS estimates, this figure will be crucial for determining market sentiment post-earnings.

How is revenue growth trending compared to previous quarters?

Revenue growth is a key indicator of the company's market position and ability to attract new customers, which will heavily influence investor confidence.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating Quest Diagnostics' ability to leverage new testing technologies to drive revenue growth this quarter.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational performance.

Options pricing suggests a limited expected move, which may not reflect the potential for a significant positive surprise.

Historical patterns show a strong tendency for the stock to react positively to earnings beats.

Key Risk

If revenue growth exceeds expectations, it could significantly shift market sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The core debate this quarter revolves around whether Quest Diagnostics can maintain its growth trajectory in a competitive healthcare landscape.

Bull Confirmed If

An EPS of $2.60 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $2.40 could signal potential issues with revenue generation and market competition.

Pre-Earnings Positioning

Options Market

Implied Move

±2.31%

Historical Avg

±5.7%

Pricing cheap

The options market is pricing a relatively modest move in the stock, suggesting that traders expect limited volatility around the earnings announcement.

Options are pricing ±2.3% while DGX has averaged ±5.7% over the last 8 prints — setup is pricing cheap.

Detail

ATM IV

0.3%

30d HV

24.2%

Calls (31K)P/C Ratio: 0.25Puts (1K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options pricing cheap in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Quest Diagnostics beats expectations, history suggests the stock could rise by an average of 3.85%, confirming strong operational health.

In-Line / Cautious

If results are in line with expectations, the stock may experience muted movement as investors await further guidance.

Miss

A miss could lead to a decline, with history indicating an average drop of 3.03% following earnings misses.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new testing technologies being introduced.
2Management's commentary on operational efficiency improvements.
3Insights into customer demand trends for diagnostic services.
4Any changes to guidance for the upcoming quarters.
5Details on competitive pressures in the healthcare market.